Cipla Q2 FY27 Profit Falls 35% to ₹878 Crore as One India Posts Record Quarter and US Inhaler Pipeline Builds

Cipla’s consolidated net profit fell about 35% year-on-year to ₹878 crore in Q2 FY27 on revenue of ₹7,404 crore, but its One India business logged its highest-ever quarterly sales, margins improved sequentially, and the company is leaning on its US inhalation pipeline and a Keytruda biosimilar partnership for growth.